CeCors Inc (CEOS)
OTHER OTC:CEOS
CEOS Stock Chart & Stats
$0.01
<$0.01(3.26%)
At close: 4:00 PM EST
$0.01
<$0.01(3.26%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.04
Previous CloseN/A
Volume431.47K
Average Volume (3M)128.10K
Market Cap
$1.63M
Enterprise Value-$469.05K
Total Cash (Recent Filing)$1.05M
Total Debt (Recent Filing)$1.11M
Price to Earnings (P/E)0.6
Beta-0.25
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding313,079,830
10 Day Avg. Volume147,110
30 Day Avg. Volume128,105
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.54
Price to Sales (P/S)0.00
P/FCF Ratio0.96
Enterprise Value/Market Cap-0.29
Enterprise Value/Revenue-0.20
Enterprise Value/Gross Profit-0.20
Enterprise Value/Ebitda0.36
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CEOS FAQ
What was CeCors Inc’s price range in the past 12 months?
CeCors Inc lowest stock price was <$0.01 and its highest was $0.04 in the past 12 months.
What is CeCors Inc’s market cap?
CeCors Inc’s market cap is $1.63M.
When is CeCors Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were CeCors Inc’s earnings last quarter?
Currently, no data Available
Is CeCors Inc overvalued?
According to Wall Street analysts CeCors Inc’s price is currently Overvalued.
Does CeCors Inc pay dividends?
CeCors Inc does not currently pay dividends.
What is CeCors Inc’s EPS estimate?
CeCors Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CeCors Inc have?
CeCors Inc has 313,079,830 shares outstanding.
What happened to CeCors Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of CeCors Inc?
Currently, no hedge funds are holding shares in CEOS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
CeCors Inc
Psykey, Inc. is dedicated to the exploration, formulation, and market introduction of specialized ingredients and compounds, including entheogenic, adaptogenic, and nootropic substances. These are incorporated into its functional product lines, which aim to enhance and optimize overall well-being. Furthermore, the company develops cutting-edge technologies focused on the makeup, bioavailability, and targeted administration of entheogen-derived therapeutics within the burgeoning psychedelic industry. Among its consumer offerings are functional mushroom coffees and teas, a variety of oral supplements, and convenient single-serve beverage mixes. The entity, which was established in Toronto, Canada, in 2002, previously operated as CeCors, Inc. before officially adopting the name Psykey, Inc. in August 2021.
Technical Analysis
Milestone Scientific
―
GlucoTrack
―
―
Innovative Eyewear, Inc.
―
WORK Medical Technology Group LTD
―
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---